For the purpose of this podcast, we're referring to compounded Semaglutide or Tirzepatide as GLP-1s. A compounded drug might be appropriate if a patient’s medical need cannot be met by an FDA-approved drug, or the FDA-approved drug is not commercially available. However, compounded drugs are not FDA-approved. 

Per FDA regulations enacted under the Drug Quality and Security Act (DQSA), Section 503A permits compounding of drug products “as customized therapies for identified individual patients whose medical needs cannot be met by commercially available drug products. GLP-1s may be prescribed to combat injury, age-related decline and other metabolic conditions. These uses are considered off-label and not officially approved.

Losing weight is easier said than done, particularly for those who have tried everything and never had lasting results. So it's no surprise that weight loss drugs like semaglutide and tirzepatide have become popular alternatives to traditional weight loss strategies.

But are these weight loss drugs right for you, and which option is better?

Today on The Dr. Kris Podcast, Dr. Kris and guest Leonard Pastrana dive deep into the growing world of weight loss drugs and compare the two biggest options. Tune in to find out:

• How these drugs cause weight loss;
• The potential benefits and risks; and
• Whether you're a good candidate for either option.